$ONCS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ONCOSEC MEDICAL Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ONCOSEC MEDICAL Inc. Get notifications about new insider transactions in ONCOSEC MEDICAL Inc for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2021 | ONCS | ONCOSEC MEDICAL In ... | Smith Kevin Raymond Merrill | Director | Option Exercise | A | 3.16 | 25,000 | 79,000 | 25,000 | |
| Jun 29 2021 | ONCS | ONCOSEC MEDICAL In ... | Zhou Chao | Director | Option Exercise | A | 3.16 | 25,000 | 79,000 | 25,000 | |
| Jun 29 2021 | ONCS | ONCOSEC MEDICAL In ... | Ward Robert | Director | Option Exercise | A | 3.16 | 25,000 | 79,000 | 25,000 | |
| Jun 29 2021 | ONCS | ONCOSEC MEDICAL In ... | Ward Robert | Director | Option Exercise | A | 3.16 | 25,000 | 79,000 | 25,000 | |
| May 04 2021 | ONCS | ONCOSEC MEDICAL In ... | DelAversano Robert J | VP, Finance | Sell | S | 4.86 | 453 | 2,202 | 24,980 | 25.4 K to 25 K (-1.78 %) |
| May 04 2021 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 4.86 | 3,172 | 15,416 | 96,097 | 99.3 K to 96.1 K (-3.20 %) |
| Apr 26 2021 | ONCS | ONCOSEC MEDICAL In ... | China Grand Pharmaceutical & H ... | 10% Owner | Buy | P | 3.45 | 281,968 | 972,790 | 3,359,607 | 3.1 M to 3.4 M (+9.16 %) |
| Apr 26 2021 | ONCS | ONCOSEC MEDICAL In ... | China Grand Pharmaceutical & H ... | 10% Owner | Buy | P | 3.45 | 1,409,838 | 4,863,941 | 16,798,036 | 15.4 M to 16.8 M (+9.16 %) |
| Feb 23 2021 | ONCS | ONCOSEC MEDICAL In ... | Alpha Holdings, Inc. | Director | Option Exercise | X | 3.45 | 368,250 | 1,270,463 | 0 | |
| Feb 23 2021 | ONCS | ONCOSEC MEDICAL In ... | Alpha Holdings, Inc. | Director | Buy | X | 3.45 | 368,250 | 1,270,463 | 1,718,251 | 1.4 M to 1.7 M (+27.28 %) |
| Feb 17 2021 | ONCS | ONCOSEC MEDICAL In ... | Leuthner Brian A | Chief Operating Off ... | Option Exercise | A | 7.45 | 150,000 | 1,117,500 | 150,000 | |
| Feb 03 2021 | ONCS | ONCOSEC MEDICAL In ... | DelAversano Robert J | Principal Accountin ... | Grant | A | 0.00 | 8,750 | 0 | 25,433 | 16.7 K to 25.4 K (+52.45 %) |
| Feb 02 2021 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 7.71 | 3,413 | 26,314 | 99,269 | 102.7 K to 99.3 K (-3.32 %) |
| Jan 27 2021 | ONCS | ONCOSEC MEDICAL In ... | China Grand Pharmaceutical & H ... | 10% Owner | Buy | P | 5.45 | 677,839 | 3,694,223 | 3,077,639 | 2.4 M to 3.1 M (+28.25 %) |
| Jan 27 2021 | ONCS | ONCOSEC MEDICAL In ... | China Grand Pharmaceutical & H ... | 10% Owner | Buy | P | 5.45 | 3,389,198 | 18,471,129 | 15,388,198 | 12 M to 15.4 M (+28.25 %) |
| Nov 23 2020 | ONCS | ONCOSEC MEDICAL In ... | Alpha Holdings, Inc. | Director | Sell | S | 4.92 | 80,000 | 393,872 | 1,350,001 | 1.4 M to 1.4 M (-5.59 %) |
| Nov 23 2020 | ONCS | ONCOSEC MEDICAL In ... | Alpha Holdings, Inc. | Director | Sell | S | 4.92 | 80,000 | 393,872 | 1,350,001 | 1.4 M to 1.4 M (-5.59 %) |
| Nov 20 2020 | ONCS | ONCOSEC MEDICAL In ... | Alpha Holdings, Inc. | Director | Sell | S | 5.10 | 50,000 | 255,230 | 1,430,001 | 1.5 M to 1.4 M (-3.38 %) |
| Nov 19 2020 | ONCS | ONCOSEC MEDICAL In ... | Alpha Holdings, Inc. | Director | Sell | S | 5.24 | 10,999 | 57,652 | 1,480,001 | 1.5 M to 1.5 M (-0.74 %) |
| Nov 19 2020 | ONCS | ONCOSEC MEDICAL In ... | Alpha Holdings, Inc. | Director | Sell | S | 5.24 | 40,000 | 209,664 | 1,491,000 | 1.5 M to 1.5 M (-2.61 %) |
| Nov 18 2020 | ONCS | ONCOSEC MEDICAL In ... | Alpha Holdings, Inc. | Director | Sell | S | 5.17 | 40,000 | 206,744 | 1,531,000 | 1.6 M to 1.5 M (-2.55 %) |
| Nov 18 2020 | ONCS | ONCOSEC MEDICAL In ... | Alpha Holdings, Inc. | Director | Sell | S | 5.41 | 40,000 | 216,328 | 1,571,000 | 1.6 M to 1.6 M (-2.48 %) |
| Nov 03 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 3.79 | 3,280 | 12,431 | 102,682 | 106 K to 102.7 K (-3.10 %) |
| Sep 16 2020 | ONCS | ONCOSEC MEDICAL In ... | DALESANDRO MARGARET | Director | Option Exercise | A | 3.43 | 25,000 | 85,750 | 25,000 | |
| Sep 16 2020 | ONCS | ONCOSEC MEDICAL In ... | DEMESA JAMES M | Director | Option Exercise | A | 3.43 | 50,000 | 171,500 | 50,000 | |
| Sep 16 2020 | ONCS | ONCOSEC MEDICAL In ... | Ward Robert | Director | Option Exercise | A | 3.43 | 25,000 | 85,750 | 25,000 | |
| Sep 16 2020 | ONCS | ONCOSEC MEDICAL In ... | Lyerly Herbert Kim | Director | Option Exercise | A | 3.43 | 25,000 | 85,750 | 25,000 | |
| Aug 26 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Option Exercise | A | 3.82 | 152,000 | 580,640 | 152,000 | |
| Aug 26 2020 | ONCS | ONCOSEC MEDICAL In ... | Foerter Kellie Malloy | Chief Operating Off ... | Option Exercise | A | 3.82 | 65,000 | 248,300 | 65,000 | |
| Aug 26 2020 | ONCS | ONCOSEC MEDICAL In ... | DelAversano Robert J | Principal Accountin ... | Option Exercise | A | 3.82 | 27,000 | 103,140 | 27,000 | |
| Aug 21 2020 | ONCS | ONCOSEC MEDICAL In ... | China Grand Pharmaceutical & H ... | 10% Owner | Buy | P | 3.25 | 399,800 | 1,299,350 | 2,399,800 | 2 M to 2.4 M (+19.99 %) |
| Aug 21 2020 | ONCS | ONCOSEC MEDICAL In ... | China Grand Pharmaceutical & H ... | 10% Owner | Buy | P | 3.25 | 1,999,000 | 6,496,750 | 11,999,000 | 10 M to 12 M (+19.99 %) |
| Aug 05 2020 | ONCS | ONCOSEC MEDICAL In ... | Foerter Kellie Malloy | Chief Operating Off ... | Option Exercise | A | 3.30 | 30,000 | 99,000 | 30,000 | |
| Aug 04 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 4.20 | 3,133 | 13,159 | 105,962 | 109.1 K to 106 K (-2.87 %) |
| Aug 04 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 4.20 | 3,133 | 13,159 | 105,962 | 109.1 K to 106 K (-2.87 %) |
| Jun 03 2020 | ONCS | ONCOSEC MEDICAL In ... | Smith Kevin Raymond Merrill | Director | Option Exercise | A | 1.56 | 25,000 | 39,000 | 25,000 | |
| Jun 03 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Option Exercise | A | 1.56 | 304,000 | 474,240 | 304,000 | |
| Jun 03 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Payment of Exercise | F | 2.23 | 44,471 | 99,170 | 109,095 | 153.6 K to 109.1 K (-28.96 %) |
| Jun 03 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Grant | A | 0.00 | 90,580 | 0 | 153,566 | 63 K to 153.6 K (+143.81 %) |
| Jun 03 2020 | ONCS | ONCOSEC MEDICAL In ... | Lyerly Herbert Kim | Director | Option Exercise | A | 1.56 | 25,000 | 39,000 | 25,000 | |
| Jun 03 2020 | ONCS | ONCOSEC MEDICAL In ... | Kim Joon | Director | Option Exercise | A | 1.56 | 25,000 | 39,000 | 25,000 | |
| Jun 03 2020 | ONCS | ONCOSEC MEDICAL In ... | DEMESA JAMES M | Director | Option Exercise | A | 1.56 | 37,500 | 58,500 | 37,500 | |
| Jun 03 2020 | ONCS | ONCOSEC MEDICAL In ... | DelAversano Robert J | Principal Accountin ... | Option Exercise | A | 1.56 | 54,054 | 84,324 | 54,054 | |
| Jun 03 2020 | ONCS | ONCOSEC MEDICAL In ... | DelAversano Robert J | Principal Accountin ... | Payment of Exercise | F | 2.23 | 8,679 | 19,354 | 16,683 | 25.4 K to 16.7 K (-34.22 %) |
| Jun 03 2020 | ONCS | ONCOSEC MEDICAL In ... | DelAversano Robert J | Principal Accountin ... | Grant | A | 0.00 | 25,362 | 0 | 25,362 | 0 to 25.4 K |
| Jun 03 2020 | ONCS | ONCOSEC MEDICAL In ... | Zhou Chao | Director | Option Exercise | A | 1.56 | 25,000 | 39,000 | 25,000 | |
| Jun 03 2020 | ONCS | ONCOSEC MEDICAL In ... | DALESANDRO MARGARET | Director | Option Exercise | A | 1.56 | 37,500 | 58,500 | 37,500 | |
| Jun 03 2020 | ONCS | ONCOSEC MEDICAL In ... | Zhao Yuhang | Director | Option Exercise | A | 1.56 | 25,000 | 39,000 | 25,000 | |
| Jun 03 2020 | ONCS | ONCOSEC MEDICAL In ... | Ward Robert | Director | Option Exercise | A | 1.56 | 25,000 | 39,000 | 25,000 | |
| May 04 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 1.79 | 3,075 | 5,504 | 62,986 | 66.1 K to 63 K (-4.65 %) |
| Apr 21 2020 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Grant | A | 1.55 | 12,500 | 19,375 | 62,052 | 49.6 K to 62.1 K (+25.23 %) |
| Apr 21 2020 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Grant | A | 1.55 | 12,500 | 19,375 | 62,052 | 49.6 K to 62.1 K (+25.23 %) |
| Feb 03 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 1.96 | 2,654 | 5,202 | 66,061 | 68.7 K to 66.1 K (-3.86 %) |
| Jan 21 2020 | ONCS | ONCOSEC MEDICAL In ... | Bonstein Sara | CFO/COO | Sell | S | 2.08 | 1,351 | 2,810 | 41,389 | 42.7 K to 41.4 K (-3.16 %) |
| Nov 01 2019 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 2.16 | 2,128 | 4,596 | 68,715 | 70.8 K to 68.7 K (-3.00 %) |
| Nov 01 2019 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 2.16 | 2,128 | 4,596 | 68,715 | 70.8 K to 68.7 K (-3.00 %) |
| Oct 18 2019 | ONCS | ONCOSEC MEDICAL In ... | Bonstein Sara | CFO/COO | Sell | S | 2.01 | 1,111 | 2,233 | 42,740 | 43.9 K to 42.7 K (-2.53 %) |
| Oct 18 2019 | ONCS | ONCOSEC MEDICAL In ... | Bonstein Sara | CFO/COO | Sell | S | 2.01 | 1,111 | 2,233 | 42,740 | 43.9 K to 42.7 K (-2.53 %) |
| Aug 02 2019 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Payment of Exercise | F | 2.23 | 2,156 | 4,808 | 70,843 | 73 K to 70.8 K (-2.95 %) |
| Jul 19 2019 | ONCS | ONCOSEC MEDICAL In ... | Alpha Holdings, Inc. | Director | Buy | P | 2.57 | 30,000 | 77,100 | 1,611,000 | 1.6 M to 1.6 M (+1.90 %) |
| Jul 19 2019 | ONCS | ONCOSEC MEDICAL In ... | Alpha Holdings, Inc. | Director | Buy | P | 2.57 | 30,000 | 77,100 | 1,611,000 | 1.6 M to 1.6 M (+1.90 %) |
| Jul 18 2019 | ONCS | ONCOSEC MEDICAL In ... | Bonstein Sara | CFO/COO | Payment of Exercise | F | 2.42 | 1,111 | 2,689 | 43,851 | 45 K to 43.9 K (-2.47 %) |
| Jul 18 2019 | ONCS | ONCOSEC MEDICAL In ... | Bonstein Sara | CFO/COO | Payment of Exercise | F | 2.42 | 1,111 | 2,689 | 43,851 | 45 K to 43.9 K (-2.47 %) |
| Jul 17 2019 | ONCS | ONCOSEC MEDICAL In ... | Alpha Holdings, Inc. | Director | Buy | P | 2.34 | 60,000 | 140,400 | 1,581,000 | 1.5 M to 1.6 M (+3.94 %) |
| Jul 17 2019 | ONCS | ONCOSEC MEDICAL In ... | Alpha Holdings, Inc. | Director | Buy | P | 2.34 | 60,000 | 140,400 | 1,581,000 | 1.5 M to 1.6 M (+3.94 %) |
| Jul 17 2019 | ONCS | ONCOSEC MEDICAL In ... | Alpha Holdings, Inc. | Director | Buy | P | 2.22 | 30,000 | 66,600 | 1,521,000 | 1.5 M to 1.5 M (+2.01 %) |
| Jul 17 2019 | ONCS | ONCOSEC MEDICAL In ... | Alpha Holdings, Inc. | Director | Buy | P | 2.22 | 30,000 | 66,600 | 1,521,000 | 1.5 M to 1.5 M (+2.01 %) |
| May 24 2019 | ONCS | ONCOSEC MEDICAL In ... | Alpha Holdings, Inc. | Director | Option Exercise | P | 3.45 | 368,250 | 1,270,463 | 368,250 | |
| May 24 2019 | ONCS | ONCOSEC MEDICAL In ... | Alpha Holdings, Inc. | Director | Buy | P | 3.14 | 491,000 | 1,541,740 | 10,491,000 | 10 M to 10.5 M (+4.91 %) |
| May 02 2019 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Payment of Exercise | F | 0.57 | 21,357 | 12,067 | 729,992 | 751.3 K to 730 K (-2.84 %) |
| Apr 26 2019 | ONCS | ONCOSEC MEDICAL In ... | DALESANDRO MARGARET | Director | Option Exercise | A | 0.58 | 100,000 | 58,000 | 100,000 | |
| Apr 18 2019 | ONCS | ONCOSEC MEDICAL In ... | Bonstein Sara | CFO/COO | Payment of Exercise | F | 0.60 | 11,102 | 6,662 | 449,629 | 460.7 K to 449.6 K (-2.41 %) |
| Feb 01 2019 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Payment of Exercise | F | 0.88 | 25,318 | 22,280 | 751,349 | 776.7 K to 751.3 K (-3.26 %) |
| Jan 18 2019 | ONCS | ONCOSEC MEDICAL In ... | Bonstein Sara | CFO/COO | Payment of Exercise | F | 0.69 | 13,379 | 9,165 | 460,731 | 474.1 K to 460.7 K (-2.82 %) |
| Jan 04 2019 | ONCS | ONCOSEC MEDICAL In ... | DEMESA JAMES M | Director | Option Exercise | A | 0.66 | 225,000 | 147,375 | 225,000 | |
| Jan 04 2019 | ONCS | ONCOSEC MEDICAL In ... | Ward Robert | Director | Option Exercise | A | 0.66 | 50,000 | 32,750 | 50,000 | |
| Jan 04 2019 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | Director | Option Exercise | A | 0.66 | 50,000 | 32,750 | 50,000 | |
| Jan 04 2019 | ONCS | ONCOSEC MEDICAL In ... | Kim Joon | Director | Option Exercise | A | 0.66 | 50,000 | 32,750 | 50,000 | |
| Jan 04 2019 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.66 | 50,000 | 32,750 | 50,000 | |
| Jan 04 2019 | ONCS | ONCOSEC MEDICAL In ... | Mayes, Gregory T. | Director | Option Exercise | A | 0.66 | 50,000 | 32,750 | 50,000 | |
| Dec 27 2018 | ONCS | ONCOSEC MEDICAL In ... | Bonstein Sara | CFO/COO | Option Exercise | A | 0.60 | 165,000 | 99,000 | 165,000 | |
| Dec 27 2018 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Grant | A | 0.00 | 750,000 | 0 | 776,667 | 26.7 K to 776.7 K (+2,812.46 %) |
| Dec 27 2018 | ONCS | ONCOSEC MEDICAL In ... | Bonstein Sara | CFO/COO | Option Exercise | A | 0.60 | 165,000 | 99,000 | 165,000 | |
| Dec 27 2018 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Grant | A | 0.00 | 750,000 | 0 | 776,667 | 26.7 K to 776.7 K (+2,812.46 %) |
| Dec 17 2018 | ONCS | ONCOSEC MEDICAL In ... | DEMESA JAMES M | Director | Grant | A | 0.77 | 1,500 | 1,155 | 22,501 | 21 K to 22.5 K (+7.14 %) |
| Nov 26 2018 | ONCS | ONCOSEC MEDICAL In ... | DEMESA JAMES M | Director | Buy | P | 0.80 | 7,000 | 5,600 | 21,001 | 14 K to 21 K (+50.00 %) |
| Nov 26 2018 | ONCS | ONCOSEC MEDICAL In ... | DEMESA JAMES M | Director | Buy | P | 0.91 | 1,500 | 1,365 | 14,001 | 12.5 K to 14 K (+12.00 %) |
| Nov 09 2018 | ONCS | ONCOSEC MEDICAL In ... | Ward Robert | Director | Option Exercise | A | 0.84 | 100,000 | 84,000 | 100,000 | |
| Nov 07 2018 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO & President | Buy | P | 0.91 | 10,000 | 9,100 | 26,667 | 16.7 K to 26.7 K (+60.00 %) |
| Oct 18 2018 | ONCS | ONCOSEC MEDICAL In ... | Bonstein Sara | CFO/COO | Payment of Exercise | F | 1.58 | 15,405 | 24,340 | 474,110 | 489.5 K to 474.1 K (-3.15 %) |
| Jul 18 2018 | ONCS | ONCOSEC MEDICAL In ... | Bonstein Sara | CFO/COO | Payment of Exercise | F | 1.34 | 135,485 | 181,550 | 489,515 | 625 K to 489.5 K (-21.68 %) |
| Jul 18 2018 | ONCS | ONCOSEC MEDICAL In ... | Bonstein Sara | CFO/COO | Grant | A | 0.00 | 625,000 | 0 | 625,000 | 0 to 625 K |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | Director | Option Exercise | M | 0.00 | 200,000 | 0 | 0 | |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | Director | Option Exercise | M | 0.00 | 150,000 | 0 | 0 | |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | Director | Option Exercise | M | 0.00 | 125,000 | 0 | 0 | |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | Director | Sell | S | 1.31 | 45,785 | 60,070 | 485,262 | 531 K to 485.3 K (-8.62 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | Director | Sell | S | 1.38 | 5,401 | 7,453 | 531,047 | 536.4 K to 531 K (-1.01 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | Director | Sell | S | 1.40 | 7,882 | 11,043 | 536,448 | 544.3 K to 536.4 K (-1.45 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | Director | Sell | S | 1.37 | 17,480 | 24,018 | 544,330 | 561.8 K to 544.3 K (-3.11 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | Director | Sell | S | 1.40 | 23,820 | 33,300 | 561,810 | 585.6 K to 561.8 K (-4.07 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | Director | Sell | S | 1.41 | 1,021 | 1,435 | 585,630 | 586.7 K to 585.6 K (-0.17 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | Director | Sell | S | 1.42 | 14,976 | 21,236 | 586,651 | 601.6 K to 586.7 K (-2.49 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | Director | Sell | S | 1.40 | 11,035 | 15,460 | 601,627 | 612.7 K to 601.6 K (-1.80 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | Director | Sell | S | 1.42 | 55,585 | 79,042 | 612,662 | 668.2 K to 612.7 K (-8.32 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | Director | Sell | S | 1.36 | 9,310 | 12,699 | 668,247 | 677.6 K to 668.2 K (-1.37 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | Director | Sell | S | 1.39 | 28,145 | 39,009 | 677,557 | 705.7 K to 677.6 K (-3.99 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | Director | Buy | M | 0.00 | 200,000 | 0 | 705,702 | 505.7 K to 705.7 K (+39.55 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | Director | Buy | M | 0.00 | 150,000 | 0 | 505,702 | 355.7 K to 505.7 K (+42.17 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | Director | Buy | M | 0.00 | 125,000 | 0 | 355,702 | 230.7 K to 355.7 K (+54.18 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | SLANSKY RICHARD B | Chief Financial Off ... | Option Exercise | M | 0.00 | 100,000 | 0 | 0 | |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | SLANSKY RICHARD B | Chief Financial Off ... | Option Exercise | M | 0.00 | 100,000 | 0 | 0 | |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | SLANSKY RICHARD B | Chief Financial Off ... | Sell | S | 1.31 | 6,725 | 8,823 | 270,016 | 276.7 K to 270 K (-2.43 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | SLANSKY RICHARD B | Chief Financial Off ... | Sell | S | 1.38 | 2,420 | 3,340 | 276,741 | 279.2 K to 276.7 K (-0.87 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | SLANSKY RICHARD B | Chief Financial Off ... | Sell | S | 1.40 | 3,532 | 4,948 | 279,161 | 282.7 K to 279.2 K (-1.25 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | SLANSKY RICHARD B | Chief Financial Off ... | Sell | S | 1.37 | 7,832 | 10,761 | 282,693 | 290.5 K to 282.7 K (-2.70 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | SLANSKY RICHARD B | Chief Financial Off ... | Sell | S | 1.40 | 10,673 | 14,921 | 290,525 | 301.2 K to 290.5 K (-3.54 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | SLANSKY RICHARD B | Chief Financial Off ... | Sell | S | 1.41 | 458 | 643 | 301,198 | 301.7 K to 301.2 K (-0.15 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | SLANSKY RICHARD B | Chief Financial Off ... | Sell | S | 1.42 | 6,710 | 9,515 | 301,656 | 308.4 K to 301.7 K (-2.18 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | SLANSKY RICHARD B | Chief Financial Off ... | Sell | S | 1.40 | 4,944 | 6,927 | 308,366 | 313.3 K to 308.4 K (-1.58 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | SLANSKY RICHARD B | Chief Financial Off ... | Sell | S | 1.42 | 24,906 | 35,416 | 313,310 | 338.2 K to 313.3 K (-7.36 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | SLANSKY RICHARD B | Chief Financial Off ... | Sell | S | 1.36 | 4,171 | 5,689 | 338,216 | 342.4 K to 338.2 K (-1.22 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | SLANSKY RICHARD B | Chief Financial Off ... | Sell | S | 1.39 | 12,613 | 17,482 | 342,387 | 355 K to 342.4 K (-3.55 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | SLANSKY RICHARD B | Chief Financial Off ... | Buy | M | 0.00 | 100,000 | 0 | 355,000 | 255 K to 355 K (+39.22 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | SLANSKY RICHARD B | Chief Financial Off ... | Buy | M | 0.00 | 100,000 | 0 | 255,000 | 155 K to 255 K (+64.52 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Option Exercise | M | 0.00 | 100,000 | 0 | 0 | |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.31 | 3,100 | 4,067 | 143,427 | 146.5 K to 143.4 K (-2.12 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.38 | 1,066 | 1,471 | 146,527 | 147.6 K to 146.5 K (-0.72 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.40 | 1,556 | 2,180 | 147,593 | 149.1 K to 147.6 K (-1.04 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.37 | 3,451 | 4,742 | 149,149 | 152.6 K to 149.1 K (-2.26 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.40 | 4,703 | 6,575 | 152,600 | 157.3 K to 152.6 K (-2.99 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.41 | 202 | 284 | 157,303 | 157.5 K to 157.3 K (-0.13 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.42 | 2,956 | 4,192 | 157,505 | 160.5 K to 157.5 K (-1.84 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.40 | 2,178 | 3,051 | 160,461 | 162.6 K to 160.5 K (-1.34 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.42 | 10,973 | 15,604 | 162,639 | 173.6 K to 162.6 K (-6.32 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.36 | 1,838 | 2,507 | 173,612 | 175.5 K to 173.6 K (-1.05 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.39 | 5,552 | 7,695 | 175,450 | 181 K to 175.5 K (-3.07 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Buy | M | 0.00 | 100,000 | 0 | 181,002 | 81 K to 181 K (+123.45 %) |
| May 07 2018 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | Chief Executive Off ... | Option Exercise | A | 1.47 | 250,000 | 367,500 | 2,850,000 | |
| May 07 2018 | ONCS | ONCOSEC MEDICAL In ... | SLANSKY RICHARD B | Chief Financial Off ... | Option Exercise | A | 1.47 | 100,000 | 147,000 | 447,500 | |
| Feb 09 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | President | Option Exercise | A | 0.00 | 200,000 | 0 | 475,583 | |
| Feb 09 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | President | Option Exercise | A | 0.00 | 200,000 | 0 | 475,583 | |
| Feb 09 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | President | Option Exercise | A | 1.64 | 300,000 | 492,000 | 1,114,583 | |
| Feb 09 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | President | Option Exercise | A | 1.64 | 300,000 | 492,000 | 1,114,583 | |
| Feb 09 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Option Exercise | A | 1.64 | 350,000 | 574,000 | 647,916 | |
| Feb 09 2018 | ONCS | ONCOSEC MEDICAL In ... | DEMESA JAMES M | Director | Option Exercise | A | 1.64 | 50,000 | 82,000 | 176,500 | |
| Feb 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | President | Buy | P | 0.88 | 3,000 | 2,640 | 230,702 | 227.7 K to 230.7 K (+1.32 %) |
| Feb 06 2018 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO | Buy | P | 1.50 | 16,667 | 25,001 | 16,667 | 0 to 16.7 K |
| Jan 17 2018 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO | Option Exercise | A | 1.25 | 500,000 | 625,000 | 500,000 | |
| Jan 17 2018 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO | Option Exercise | A | 1.25 | 2,000,000 | 2,500,000 | 2,000,000 | |
| Jan 17 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | President | Option Exercise | A | 1.32 | 250,000 | 330,000 | 814,583 |